Table 1:

Characteristics of BM among primary lung cancer groups

Total (n = 74)Adenocarcinoma (n = 56)Small-Cell Lung Cancer (n = 11)Squamous Cell Carcinoma (n = 7)P Value
DWI visual score1.87 ± 0.762.27 ± 0.901.85 ± 0.69.298
ADCmin (×10−6mm2/s)615.23 ± 166.83623.38 ± 163.07531.18 ± 160.54682.14 ± 182.07.131
nADC ratio1.02 ± 0.281.04 ± 0.280.88 ± 0.21.11 ± 0.28.144
Age (yr)64.19 ± 10.7663.63 ± 11.1568.09 ± 9.1462.57 ± 9.73.420
Male sex50 (67.57)36 (64.29)9 (81.82)5 (71.43).587
Site of BM.545
    Anterior circulation—dominanta25 (33.78)21 (37.5)2 (18.18)2 (28.57)
    Posterior circulation—dominantb11 (14.86)7 (12.5)2 (18.18)2 (28.57)
    Even distribution38 (51.35)28 (50)7 (63.64)3 (42.86)
No. of BMs.051
    118 (24.32)16 (28.57)0 (0)2 (28.57)
    1<BM<1043 (58.11)32 (57.14)6 (54.55)5 (71.43)
    ≥1013 (17.57)8 (14.29)5 (45.45)0 (0)
Target lesion size of BM.367
    <10 mm31 (41.89)22 (39.29)7 (63.64)2 (28.57)
    10 mm≤BM<30 mm32 (43.24)24 (42.86)3 (27.27)5 (71.43)
    ≥30 mm11 (14.86)10 (17.86)1 (9.09)0 (0)
Intratumoral necrosis32 (43.24)21 (37.5)6 (54.55)5 (71.43).160
Intratumoral hemorrhage15 (20.27)11 (19.64)3 (27.27)1 (14.29).882
  • a BMs mainly located in the frontal, parietal, and temporal lobes.

  • b BMs mainly located in the occipital lobes, cerebellum, and brain stem.